1,000 Followers in Under a Year — Thank You for Joining the Trilliome Journey

We just crossed 1,000 followers - thank you! At Trilliome, we’re programming the gut microbiome to boost anti-inflammatory, senescence-modulating, and neurotransmitter-supporting metabolites - turning deep biotech into scalable solutions for healthy aging.
1,000 Followers in Under a Year — Thank You for Joining the Trilliome Journey

We just crossed 1,000 followers on LinkedIn (and counting). 🎉
To everyone who’s been reading, sharing, challenging our thinking, or simply cheering from the sidelines: thank you. You’re helping shape what we build—and how fast we build it.

But this milestone isn’t just a number. It’s a signal that more people are asking the same question we are:

What if healthy aging isn’t won by adding “one more supplement”… but by strengthening the body’s internal protective systems?

That’s the bet we’re making at Trilliome.


Healthy Aging Won’t Be “One More Ingredient”

The next wave of preventive health won’t come from piling more products on top of a struggling biology.

We believe healthy aging will be driven by amplifying what the body already does best—if you give it the right signals.

And one of the most powerful signal hubs we have is the gut.


We Treat the Gut Like a High-Output Production Plant 🏭

The gut microbiome is not just a passive ecosystem. It’s an active biochemical factory.

When the right microbial networks are present—and properly “programmed”—they can produce compounds that influence:

  • inflammation,
  • cellular resilience,
  • metabolism,
  • and even cognition.

So rather than “spraying and praying” with broad ingredients, we focus on precision programming: identifying bioactives that can selectively increase specific microbial networks and the beneficial molecules they produce.


How We Do It: In Silico Discovery + Advanced In Vitro Gut Models

At Trilliome, we combine:

  • an in silico discovery stack to identify promising candidates efficiently, and
  • advanced in vitro gut models to validate and refine how those candidates shape microbial behavior.

This approach helps us move faster, learn earlier, and build toward products that can scale.


What We’re Engineering the Microbiome to Produce

Our goal is to dramatically increase targeted networks of gut microbes to increase the production of:

🔥 Anti-inflammatory mediators
Supporting a healthier inflammatory balance over time.

🧬 Senescence-modulating compounds
Supporting cellular resilience and long-term tissue function.

🧠 Neurotransmitter-supporting metabolites
Supporting cognitive resilience and brain health.


From Deep Biotech to Scalable Consumer Solutions

We’re translating this into consumer-friendly products with a clear path to scale across:

  • Brain Health
  • Metabolic Health
  • Women’s Health
  • Gut Health

Our north star: deep science, measurable outcomes, scalable products.


What’s Next: Learning on the Ground in Dubai

We’re also not building in a vacuum.

Our co-founder Tim Mak is currently in Dubai, representing Trilliome at leading longevity and microbiome events—connecting with researchers, operators, and partners and bringing back the latest on where the field is heading.

We’re here to learn, exchange insights, and build bridges between ecosystems.


If You Care About Deep Science With a Clear Path to Scale, We Should Talk

If you’re working on:

  • microbiome innovation,
  • platform biology,
  • or preventive health at scale,

…we’d love to connect.

To investors and partners focused on science that can become real-world products, we’re happy to share more about our roadmap and where we think the biggest breakthroughs will come from next.

Onward 🥂
— Trilliome

Member discussion